A critical advance in cancer investigation is emerging with the use of VHH fragments to reactivate mutated p53. This vital cancer inhibitor protein is frequently lost in various kinds of tumors, leading uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research